Literature DB >> 23721690

Differential anti-inflammatory and analgesic effects by enantiomers of zaltoprofen in rodents.

Ig Jun Cho1, Chang Woo Lee, Myeong Youl Lee, Moo Rim Kang, Jieun Yun, Soo Jin Oh, Sang-Bae Han, Kiho Lee, Song-Kyu Park, Hwan Mook Kim, Sang-Hun Jung, Jong Soon Kang.   

Abstract

In the present study, we investigated the effect of zaltoprofen enantiomers on inflammation and pain and compared their effect with racemic zaltoprofen. S(+)-zaltoprofen potently inhibited the inflammatory response in carrageenan-induced paw edema model, whereas R(-)-zaltoprofen did not. Moreover, the anti-inflammatory effect of S(+)-zaltoprofen was stronger than that of racemic zaltoprofen, suggesting that S(+)-zaltoprofen is an active component of racemic zaltoprofen in terms of anti-inflammatory activity. In contrast, the results of acetic acid-induced writhing model demonstrated that no significant analgesic effect was observed by racemic zaltoprofen and zaltoprofen enantiomers at doses used in carrageenan-induced paw edema model. However, racemic zaltoprofen and zaltoprofen enantiomers all exerted an analgesic effect at higher doses, which is inconsistent with the result of carrageenan-induced paw edema model. Gastric ulcers induced by racemic zaltoprofen and zaltoprofen enantiomers were minimal. Taken together, these results suggest that S(+)-zaltoprofen is a potent and active anti-inflammatory component of racemic zaltoprofen, but both S(+)-zaltoprofen and R(-)-zaltoprofen might seem to contribute to the analgesic effect of racemic zaltoprofen.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23721690     DOI: 10.1016/j.intimp.2013.05.008

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  2 in total

1.  A thorough analysis of the effect of surfactant/s on the solubility and pharmacokinetics of (S)-zaltoprofen.

Authors:  Cuong Viet Pham; Jong-Suep Baek; Jong-Hun Park; Sang-Hun Jung; Jong-Seong Kang; Cheong-Weon Cho
Journal:  Asian J Pharm Sci       Date:  2018-11-02       Impact factor: 6.598

2.  In vitro anti-MRSA activity of carvone with gentamicin.

Authors:  Su-Hyun Mun; Ok-Hwa Kang; Dae-Ki Joung; Sung-Bae Kim; Jang-Gi Choi; Dong-Won Shin; Dong-Yeul Kwon
Journal:  Exp Ther Med       Date:  2014-01-23       Impact factor: 2.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.